These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3571773)

  • 21. Comparison of the intensity and duration of effects of inhaled bitolterol and albuterol on airway caliber and airway responsiveness to histamine.
    Harris JB; Ahrens RC; Milavetz G; Annis L; Ries R; Hendricker C
    J Allergy Clin Immunol; 1990 Jun; 85(6):1043-9. PubMed ID: 2191990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.
    Demirca BP; Cagan H; Kiykim A; Arig U; Arpa M; Tulunay A; Ozen A; Karakoc-Aydiner E; Baris S; Barlan IB
    Respir Med; 2015 Sep; 109(9):1120-5. PubMed ID: 26216378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
    Swystun V; Green FHY; Dennis JH; Rampakakis E; Lalli G; Fadayomi M; Chiu A; Shrestha G; El Shahat SG; Nelson DE; El Mays TY; Pieron CA; Leigh R
    Trials; 2018 Jun; 19(1):321. PubMed ID: 29914544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the bronchodilator effects of aerosol fenoterol and isoproterenol.
    Steen SN; Smith R; Kuo J; Ziment I; Beall GN
    Chest; 1977 Dec; 72(6):724-30. PubMed ID: 336305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
    Maneechotesuwan K; Suthamsmai T; Ratanasaenglert K; Pipopsuthipaiboon S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S66-71. PubMed ID: 21728272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma.
    Hinkle J; Hinson J; Kerwin E; Goodwin E; Sciarappa K; Curry L; Hanrahan JP
    Pediatr Pulmonol; 2011 Aug; 46(8):761-9. PubMed ID: 21584948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack.
    Starobin D; Bolotinsky L; Or J; Fink G; Shtoeger Z
    Isr Med Assoc J; 2008; 10(8-9):568-71. PubMed ID: 18847151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of salbutamol and bitolterol mesilate on pO2 levels in asthmatic patients and healthy volunteers.
    Dal Negro R; Cogo AL; Pomari C; Turati C; Turco P; Allegra L
    Arzneimittelforschung; 1992 Jul; 42(7):959-61. PubMed ID: 1418062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial.
    Donohue JF; Hanania NA; Fogarty C; Campbell SC; Rinehart M; Denis-Mize K
    Ther Adv Respir Dis; 2008 Aug; 2(4):199-208. PubMed ID: 19124372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults.
    Bessmertny O; DiGregorio RV; Cohen H; Becker E; Looney D; Golden J; Kohl L; Johnson T
    Ann Emerg Med; 2002 Jun; 39(6):585-91. PubMed ID: 12023699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy of nebulized budesonide in acute moderate to severe exacerbations of asthma in children].
    Chen AH; Chen RC; Zhan JY; Huang S; Lin YN; Chen DH; Yang CZ; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Apr; 35(4):269-74. PubMed ID: 22781199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder.
    Raimondi AC; Schottlender J; Lombardi D; Molfino NA
    Chest; 1997 Jul; 112(1):24-8. PubMed ID: 9228352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department.
    Rudnitsky GS; Eberlein RS; Schoffstall JM; Mazur JE; Spivey WH
    Ann Emerg Med; 1993 Dec; 22(12):1842-6. PubMed ID: 8239105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers.
    Green FH; Leigh R; Fadayomi M; Lalli G; Chiu A; Shrestha G; ElShahat SG; Nelson DE; El Mays TY; Pieron CA; Dennis JH
    Trials; 2016 Jul; 17():361. PubMed ID: 27464582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations.
    Maesen FP; Costongs R; Smeets JJ; Brombacher PJ; Zweers PG
    Chest; 1991 Jun; 99(6):1367-73. PubMed ID: 2036817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.